Charles DeBattista

Psychiatrist

Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center

Outpatient Psychiatry Clinic

  • 401 Quarry Road
  • Stanford, CA 94304
  • Phone: 650-498-9111
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: Stanford University Medical Center (1993) CA

Internship: Stanford University Medical Center (1990) CA

Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1995)

Fellowship: Stanford University Medical Center (1993) CA

Medical Education: UCSF School of Medicine (1989) CA

DMH, UCSF/UC Berkeley, Mental Health (1986)

MD, UCSF, Medicine (1989)

Honors & Awards

America's Best Doctors; Psychiatry, Best Doctors (2009-2010)

Review Article of the Year, Primary Psychiatry (2004)

Teacher of the Year, Dept. Of Psychiatry (1998, 2000, 2001)

Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review
Hoffman, D. A., DeBattista, C., Valuck, R. J., & Iosifescu, D. V. (2012). Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 8, 277-284.

The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression
DeBattista, C., Kinrys, G., Hoffman, D., Goldstein, C., Zajecka, J., & Fava, M. (2011). The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. JOURNAL OF PSYCHIATRIC RESEARCH, 45(1), 64-75.

Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effects.
DeBattista, C., & Debattista, K. (2010). Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effects. Current drug safety, 5(3), 263-266.

Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function
Gomez, R. G., Posener, J. A., Keller, J., DeBattista, C., Solvason, B., & Schatzberg, A. F. (2009). Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function. PSYCHONEUROENDOCRINOLOGY, 34(7), 1012-1018.

A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction
Blasey, C. M., DeBattista, C., Roe, R., Block, T., & Belanoff, J. K. (2009). A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction. CONTEMPORARY CLINICAL TRIALS, 30(4), 284-288.

Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression
DeBattista, C., & Hawkins, J. (2009). Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression. CNS DRUGS, 23(5), 369-377.

Sildenafil treatment of women with antidepressant-associated sexual dysfunction - A randomized controlled trial
Nurnberg, H. G., Hensley, P. L., Heiman, J. R., Croft, H. A., DeBattista, C., & Paine, S. (2008). Sildenafil treatment of women with antidepressant-associated sexual dysfunction - A randomized controlled trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 300(4), 395-404.

Depression and smoking cessation: does the evidence support psychiatric practice?
Lembke, A., Johnson, K., & DeBattista, C. (2007). Depression and smoking cessation: does the evidence support psychiatric practice?. Neuropsychiatric disease and treatment, 3(4), 487-493.

Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Fava, M., Thase, M. E., DeBattista, C., Doghramji, K., Arora, S., & Hughes, R. J. (2007). Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Annals of clinical psychiatry , 19(3), 153-159.

Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression
DeBattista, C., Belanoff, J., Glass, S., Khan, A., Horne, R. L., & Alva, G. (2006). Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. BIOLOGICAL PSYCHIATRY, 60(12), 1343-1349.

The neuropsychological profile of psychotic major depression and its relation to cortisol
Gomez, R. G., Fleming, S. H., Keller, J., Flores, B., Kenna, H., & Schatzberg, A. F. (2006). The neuropsychological profile of psychotic major depression and its relation to cortisol. BIOLOGICAL PSYCHIATRY, 60(5), 472-478.

The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats
Beebe, K. L., Block, T., DeBattista, C., Blasey, C., & Belanoff, J. K. (2006). The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats. BEHAVIOURAL BRAIN RESEARCH, 171(2), 225-229.

Augmentation and combination strategies for depression
DeBattista, C. (2006). Augmentation and combination strategies for depression. JOURNAL OF PSYCHOPHARMACOLOGY, 20(3), 11-18.

The use of mifepristone in the treatment of neuropsychiatric disorders
DeBattista, C., & Belanoff, J. (2006). The use of mifepristone in the treatment of neuropsychiatric disorders. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 17(3), 117-121.

Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: A 12-week, open-label, extension study
Thase, M. E., Fava, M., Debattista, C., Arora, S., & Hughes, R. J. (2006). Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: A 12-week, open-label, extension study. CNS SPECTRUMS, 11(2), 93-102.

Detecting psychotic major depression using psychiatric rating scales
Keller, J., Gomez, R. G., Kenna, H. A., Poesner, J., Debattista, C., & Schatzberg, A. F. (2006). Detecting psychotic major depression using psychiatric rating scales. JOURNAL OF PSYCHIATRIC RESEARCH, 40(1), 22-29.

Update on augmentation of antidepressant response in resistant depression.
DeBattista, C., & Lembke, A. (2005). Update on augmentation of antidepressant response in resistant depression. Current psychiatry reports, 7(6), 435-440.

The efficacy of divalproex sodium in the treatment of agitation associated with major depression
Debattista, C., Solomon, A., Arnow, B., Kendrick, E., Tilston, J., & Schatzberg, A. F. (2005). The efficacy of divalproex sodium in the treatment of agitation associated with major depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 25(5), 476-479.

A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction
DeBattista, C., Solvason, B., Poirier, J., Kendrick, E., & Loraas, E. (2005). A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. JOURNAL OF CLINICAL PSYCHIATRY, 66(7), 844-848.

C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease.
DeBattista, C., & Belanoff, J. (2005). C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease. Current Alzheimer research, 2(2), 125-129.

Executive dysfunction in major depressive disorder.
DeBattista, C. (2005). Executive dysfunction in major depressive disorder. Expert review of neurotherapeutics, 5(1), 79-83.

A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness
Fava, M., Thase, M. E., & Debattista, C. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. JOURNAL OF CLINICAL PSYCHIATRY, 66(1), 85-93.

HPA axis activation in major depression and response to fluoxetine: a pilot study
Young, E. A., Altemus, M., Lopez, J. F., Kocsis, J. H., Schatzberg, A. F., & Zubieta, J. K. (2004). HPA axis activation in major depression and response to fluoxetine: a pilot study. PSYCHONEUROENDOCRINOLOGY, 29(9), 1198-1204.

A prospective trial of modafinil as an adjunctive treatment of major depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004). A prospective trial of modafinil as an adjunctive treatment of major depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 24(1), 87-90.

Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy
Smith, D. L., Angst, M. S., Brock-Utne, J. G., & Debattista, C. (2003). Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 47(9), 1064-1066.

Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study
Debattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., & Fieve, R. R. (2003). Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study. JOURNAL OF CLINICAL PSYCHIATRY, 64(9), 1057-1064.

Safety of antidepressants in the elderly.
Sommer, B. R., Fenn, H., Pompei, P., DeBattista, C., Lembke, A., & Flores, B. (2003). Safety of antidepressants in the elderly. Expert opinion on drug safety, 2(4), 367-383.

A prospective trial of bupropion SR augmentation of partial and non-responders to Serotonergic antidepressants
Debattista, C., Solvason, H. B., Poirier, J., Kendrick, E., & Schatzberg, A. F. (2003). A prospective trial of bupropion SR augmentation of partial and non-responders to Serotonergic antidepressants. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 23(1), 27-30.

The timing of electroconvulsive therapy and bispectral index after anesthesia induction using different drugs does not affect seizure duration
Lemmens, H. Jm., Levi, D. C., Debattista, C., & Brock-Utne, J. G. (2003). The timing of electroconvulsive therapy and bispectral index after anesthesia induction using different drugs does not affect seizure duration. JOURNAL OF CLINICAL ANESTHESIA, 15(1), 29-32.

Fetal heart rate decelerations during ECT-induced seizures: is it important?
Debattista, C., Cochran, M., Barry, J. J., & Brock-Utne, J. G. (2003). Fetal heart rate decelerations during ECT-induced seizures: is it important?. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 47(1), 101-103.

An open label trial of C-1073 (mifepristone) for psychotic major depression
Belanoff, J. K., Rothschild, A. J., Cassidy, F., Debattista, C., Baulieu, E. E., & Schatzberg, A. F. (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression. BIOLOGICAL PSYCHIATRY, 52(5), 386-392.

Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone
Belanoff, J. K., Jurik, J., Schatzberg, L. D., Debattista, C., & Schatzberg, A. F. (2002). Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone. JOURNAL OF MOLECULAR NEUROSCIENCE, 19(1-2), 201-206.

Cortisol feedback during the HPA quiescent period in patients with major depression
Posener, J. A., Debattista, C., Williams, G. H., & Schatzberg, A. F. (2001). Cortisol feedback during the HPA quiescent period in patients with major depression. AMERICAN JOURNAL OF PSYCHIATRY, 158(12), 2083-2085.

Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder?
Debattista, C., & Mueller, K. (2001). Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder?. JOURNAL OF ECT, 17(2), 91-98.

Sertraline versus imipramine to prevent relapse in chronic depression
Koran, L. M., Gelenberg, A. J., Kornstein, S. G., Howland, R. H., Friedman, R. A., & Keller, M. B. (2001). Sertraline versus imipramine to prevent relapse in chronic depression. JOURNAL OF AFFECTIVE DISORDERS, 65(1), 27-36.

Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia
Glick, I. D., Suppes, T., Debattista, C., Hu, R. J., & Marder, S. (2001). Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia. ANNALS OF INTERNAL MEDICINE, 134(1), 47-60.

Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: A double-blind, placebo-controlled study
Debattista, C., Posener, J. A., Kalehzan, B. M., & Schatzberg, A. F. (2000). Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: A double-blind, placebo-controlled study. AMERICAN JOURNAL OF PSYCHIATRY, 157(8), 1334-1337.

24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression
Posener, J. A., Debattista, C., Williams, G. H., Kraemer, H. C., Kalehzan, B. M., & Schatzberg, A. F. (2000). 24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. ARCHIVES OF GENERAL PSYCHIATRY, 57(8), 755-760.

Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness
Schatzberg, A. F., Posener, J. A., Debattista, C., Kalehzan, B. M., Rothschild, A. J., & Shear, P. K. (2000). Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. AMERICAN JOURNAL OF PSYCHIATRY, 157(7), 1095-1100.

Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression
Debattista, C., Solvason, H. B., Breen, J. Ah., & Schatzberg, A. F. (2000). Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 20(2), 274-275.

Negative-pressure pulmonary edema: A potential mazard in patients undergoing ECT
Cochran, M., Debattista, C., Schmiesing, C., & Brock-Utne, J. G. (1999). Negative-pressure pulmonary edema: A potential mazard in patients undergoing ECT. JOURNAL OF ECT, 15(2), 168-170.

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder
Crismon, M. L., Trivedi, M., Pigott, T. A., Rush, A. J., Hirschfeld, R. Ma., & Thase, M. E. (1999). The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. JOURNAL OF CLINICAL PSYCHIATRY, 60(3), 142-156.

Phenomenology and treatment of agitation
Schatzberg, A. F., & Debattista, C. (1999). Phenomenology and treatment of agitation. JOURNAL OF CLINICAL PSYCHIATRY, 60, 17-20.

ECT in dissociative identity disorder and comorbid depression
Debattista, C., Solvason, H. B., & Spiegel, D. (1998). ECT in dissociative identity disorder and comorbid depression. JOURNAL OF ECT, 14(4), 275-279.

Serotonergic synergism: The risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs
Debattista, C., Sofuoglu, M., & Schatzberg, A. F. (1998). Serotonergic synergism: The risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs. BIOLOGICAL PSYCHIATRY, 44(5), 341-347.

Developing treatment algorithms for unipolar depression in cyberspace: International Psychopharmacology Algorithm Project (IPAP)
Trivedi, M. H., Debattista, C., Fawcett, J., Nelson, C., Osser, D. N., & Jobson, K. (1998). Developing treatment algorithms for unipolar depression in cyberspace: International Psychopharmacology Algorithm Project (IPAP). PSYCHOPHARMACOLOGY BULLETIN, 34(3), 355-359.

Treatment of psychotic depression
Debattista, C., Solvason, H. B., Belanoff, J., & Schatzberg, A. (1997). Treatment of psychotic depression. AMERICAN JOURNAL OF PSYCHIATRY, 154(11), 1625-1626.

Development of obsessive symptoms during nefazodone treatment
Sofuoglu, M., & Debattista, C. (1996). Development of obsessive symptoms during nefazodone treatment. AMERICAN JOURNAL OF PSYCHIATRY, 153(4), 577-578.

SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES
Debattista, C., & Mueller, K. (1995). SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES. HEADACHE, 35(8), 502-503.

PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL
Debattista, C., & Schatzberg, A. F. (1995). PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL. AMERICAN JOURNAL OF PSYCHIATRY, 152(8), 1235-1236.